Atria Wealth Solutions’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.4M Sell
80,696
-76,662
-49% -$11.8M 0.28% 79
2025
Q1
$26.1M Sell
157,358
-5,424
-3% -$849K 0.31% 65
2024
Q4
$23.5M Buy
162,782
+2,784
+2% +$431K 0.26% 82
2024
Q3
$25.9M Buy
159,998
+4,040
+3% +$644K 0.28% 72
2024
Q2
$22.8M Sell
155,958
-12,249
-7% -$1.82M 0.25% 80
2024
Q1
$26.6M Buy
168,207
+5,360
+3% +$853K 0.3% 62
2023
Q4
$25.5M Buy
162,847
+4,497
+3% +$690K 0.32% 61
2023
Q3
$24.7M Buy
158,350
+11,498
+8% +$1.9M 0.35% 56
2023
Q2
$24.3M Buy
146,852
+1,040
+0.7% +$168K 0.33% 56
2023
Q1
$22.6M Sell
145,812
-11,052
-7% -$1.78M 0.33% 66
2022
Q4
$27.7M Buy
156,864
+4,040
+3% +$698K 0.44% 38
2022
Q3
$25M Buy
152,824
+81,377
+114% +$13.8M 0.43% 40
2022
Q2
$12.7M Sell
71,447
-45,064
-39% -$8.03M 0.24% 96
2022
Q1
$20.6M Buy
+116,511
New +$19.8M 0.34% 59

Other funds holding JNJ

Atria Wealth Solutions's JNJ Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Johnson & Johnson (JNJ) stake by 49% in Q2 2025, selling an estimated $11.8M and leaving 80,696 shares worth $12.4M. The position accounts for 0.28% of the portfolio, ranked #79.

Atria Wealth Solutions first reported a position in JNJ in Q1 2022 and has held it in 14 quarters since. The position peaked at $27.7M in Q4 2022. 4,090 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Atria Wealth Solutions held 80,696 shares of Johnson & Johnson worth $12.4M as of Q2 2025.
  • Atria Wealth Solutions sold 76,662 Johnson & Johnson shares in Q2 2025, an estimated $11.8M.
  • Johnson & Johnson made up 0.28% of Atria Wealth Solutions's portfolio in Q2 2025, its #79 holding.
  • Atria Wealth Solutions first reported a position in Johnson & Johnson in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Johnson & Johnson position peaked at $27.7M in Q4 2022.
  • 4,090 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.